Michael “Mike” Mahoney is Chief Executive Officer of Boston Scientific Corporation and Chairman of the company’s Board of Directors. Mahoney joined Boston Scientific in 2011 as President, and became President, Chief Executive Officer and a member of the Board of Directors in 2012. He was elected Chairman in 2016. Since joining Boston Scientific, Mahoney has focused the company on addressing the needs of the evolving healthcare landscape by driving improvements to patient outcomes and increasing healthcare economic efficiency and access. Under his leadership, Boston Scientific has brought many transformational medical devices to market while creating significant value to its shareholders. Mahoney’s career spans more than 25 years of success building market-leading medical device, capital equipment and healthcare IT businesses. Prior to Boston Scientific, he served as Worldwide Chairman of the Medical Devices and Diagnostics (MD&D) division of Johnson & Johnson, where he oversaw seven franchises and 50,000 employees. Previously, he served as Worldwide Group Chairman of Johnson & Johnson’s DePuy orthopedics and neuro-sciences business, where he drove growth through product innovation, acquisitions and market expansion into China and India. Prior to joining DePuy, Mahoney was President and Chief Executive Officer of Global Healthcare Exchange (GHX), a joint venture between Johnson & Johnson, General Electric and three other leaders in the medical device, hospital and technology industries. For the first 12 years of his career, Mahoney advanced through a series of leadership roles at General Electric Medical Systems, including General Manager of the company’s Healthcare Information Technology business. Mahoney serves on the Board of Directors of Baxter International and the American Heart Association leadership council. He earned a B.B.A. in Finance from the University of Iowa and his M.B.A. from Wake Forest University.

Michael F. Mahoney focused his main research interest in healthcare economics and finance field